| 启明医疗-B |
QM22 Limited |
增持 |
20396751 |
2039.68万股 |
0.09% |
好仓 |
2019-12-10 |
| 启明医疗-B |
QM22 (BVI) Limited |
增持 |
20396751 |
2039.68万股 |
0.09% |
好仓 |
2019-12-10 |
| 招商局商业房托 |
EUREKA INVESTMENT COMPANY LIMITED |
增持 |
377819549 |
37781.95万股 |
0.34% |
好仓 |
2019-12-10 |
| 招商局商业房托 |
EUREKA INVESTMENT COMPANY LIMITED |
增持 |
377819549 |
37781.95万股 |
0.34% |
好仓 |
2019-12-10 |
| 招商局商业房托 |
China Merchants Shekou Industrial Zone Holdings Company Limited |
增持 |
377819549 |
37781.95万股 |
0.34% |
好仓 |
2019-12-10 |
| 中国抗体-B |
梁瑞安 |
增持 |
100000000 |
38946.92万股 |
0.39% |
好仓 |
2019-12-10 |
| 太平洋航运 |
HSBC Holdings plc |
增持 |
571382291 |
58570.79万股 |
0.12% |
好仓 |
2019-12-10 |
| 启明医疗-B |
Jiaxing Dechanghong Investment Partnership (Limited Partnership) |
增持 |
13628724 |
1362.87万股 |
0.06% |
好仓 |
2019-12-10 |
| 启明医疗-B |
Jiaxing Demenghong Investment Partnership (Limited Partnership) |
增持 |
13628724 |
1362.87万股 |
0.06% |
好仓 |
2019-12-10 |
| 启明医疗-B |
Muheng Capital Partners (Hong Kong) Limited |
增持 |
16690318 |
1669.03万股 |
0.10% |
好仓 |
2019-12-10 |
| 启明医疗-B |
Red Giant Limited |
增持 |
16690318 |
1669.03万股 |
0.10% |
好仓 |
2019-12-10 |
| 启明医疗-B |
DCP Capital Partners, L.P. |
增持 |
16690318 |
1669.03万股 |
0.10% |
好仓 |
2019-12-10 |
| 启明医疗-B |
DCP General Partner, Ltd |
增持 |
16690318 |
1669.03万股 |
0.10% |
好仓 |
2019-12-10 |
| 启明医疗-B |
DCP, Ltd. |
增持 |
16690318 |
1669.03万股 |
0.10% |
好仓 |
2019-12-10 |
| 启明医疗-B |
Ming Zhi Investments (BVI) Limited |
增持 |
16788728 |
1678.87万股 |
0.08% |
好仓 |
2019-12-10 |
| 启明医疗-B |
Wolhardt Julian Juul |
增持 |
16690318 |
1669.03万股 |
0.10% |
好仓 |
2019-12-10 |
| 启明医疗-B |
刘海峰 |
增持 |
16690318 |
1669.03万股 |
0.10% |
好仓 |
2019-12-10 |
| 启明医疗-B |
SCC Venture IV-Bright (HK) Limited |
增持 |
18522200 |
1852.22万股 |
0.08% |
好仓 |
2019-12-10 |
| 启明医疗-B |
Sequoia Capital China Venture Fund IV, L.P. |
增持 |
18522200 |
1852.22万股 |
0.08% |
好仓 |
2019-12-10 |
| 启明医疗-B |
SC China Venture IV Management, L.P. |
增持 |
18522200 |
1852.22万股 |
0.08% |
好仓 |
2019-12-10 |
